Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Leukemia, Myeloid, Acute 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Congenital Abnormalities 1Breast Neoplasms 1Blast Crisis 1

Interventions

Cyclophosphamide 59Peripheral Blood Stem Cell Transplantation 51fludarabine phosphate 47Busulfan 39Tacrolimus 38Methotrexate 35Mycophenolic Acid 31Filgrastim 30Cyclosporine 30Cytarabine 29Whole-Body Irradiation 28Antilymphocyte Serum 28Radiotherapy 22Methylprednisolone 18Etoposide 18Melphalan 17Cord Blood Stem Cell Transplantation 17Imatinib Mesylate 13Flow Cytometry 13Thiotepa 11Therapeutics 11merphos 10fludarabine 10Granulocyte Colony-Stimulating Factor 10Sirolimus 8Rituximab 8Psychiatric Rehabilitation 8Prednisone 8sargramostim 7Dexamethasone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Blast Crisis × alvocidib × Clear all
NCT00064285 2010-05-03

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

Virginia Commonwealth University

Phase 1 Completed
22 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡